Ledger.Open graph →
SEC Form D · Amendment · filed March 12, 2021

Rgenta Therapeutics, Inc

Offering
$38.0M
Sold
$10.0M
Exemption
Rule 506(b)
Industry
Other
Location
Cambridge, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Martin S. Heidecker · Cambridge, MADirectorZhiping S. Weng · Cambridge, MADirectorHualin S. Xi · Cambridge, MAExec · DirectorTravis S. Wager · Cambridge, MAExecSun S. Linghao · Cambridge, MADirectorPeter Lamson · New York, NYDirectorGregory Goulder · San Francisco, CADirectorOwen E. Meyer · East Setauket, NYExec · DirectorHaley Ulloa · Baltimore, MDDirectorJoseph Bohm · New York, NYExecJudith S. Li · Cambridge, MADirectorHongbo S. Lu · Cambridge, MADirectorDebasish S. Roychowdhury · Cambridge, MADirectorThomas L. Wilkes · Atlanta, GADirectorLynda T. Ausburn · Atlanta, GAExec · DirectorDavid K. Loeffel · Atlanta, GADirectorLauren M. Johnson · Atlanta, GADirectorL. B. Teague · Atlanta, GAExecJudith S. Li · Cambridge, MADirectorHongbo S. Lu · Cambridge, MADirectorDebasish S. Roychowdhury · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗